Heart Test Laboratories announced that it has been granted Indian Patent Application 201817014481 by the Indian Patent Office, IPO. To date, HeartSciences has been granted nine US patents and 35 international patents for a total of 44 granted patents. Issued international patents are across key countries including China, Brazil, Canada, India, South Korea, Mexico, and key European markets such as Germany, France, UK, Italy and the Netherlands.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSCS:
- Heart Test Laboratories Inc trading halted, news pending
- HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
- Heart Test Laboratories announces EPO application EP3834729 granted
- HeartSciences to Present at the LD Micro Invitational XIV Conference
- Heart Test Laboratories announces podium presentation on MyoVista wavECG